Have your own idea? Try our Stock Screener
Swedish (OMX) Pharma Industry Analysis
UpdatedJan 24, 2025
DataAggregated Company Financials
Companies27
- 7D1.8%
- 3M-0.9%
- 1Y2.0%
- YTD1.9%
Over the last 7 days, the Pharma industry has risen 4.2%, driven by gains from Camurus of 4.4%. During this same period, the Dicot Pharma underperformed, falling 14%. Overall in the last year, the industry is flat. Earnings are forecast to grow by 76% annually.
Industry Valuation and Performance
Has the Swedish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 24 Jan 2025 | SEK 48.4b | SEK 4.4b | -SEK 580,886,482.76 | 132.1x | -83.3x | 10.9x |
| Sun, 22 Dec 2024 | SEK 50.0b | SEK 4.4b | -SEK 615,836,627.11 | 124.5x | -81.1x | 11.2x |
| Tue, 19 Nov 2024 | SEK 48.4b | SEK 4.4b | -SEK 629,146,451.06 | 120.6x | -77x | 10.9x |
| Thu, 17 Oct 2024 | SEK 52.9b | SEK 4.3b | -SEK 676,928,614.47 | 140.2x | -78.1x | 12.3x |
| Sat, 14 Sep 2024 | SEK 68.1b | SEK 5.9b | -SEK 1,169,937,604.05 | 180.3x | -58.2x | 11.6x |
| Mon, 12 Aug 2024 | SEK 67.4b | SEK 5.6b | -SEK 993,346,440.24 | 89.8x | -67.9x | 12x |
| Wed, 10 Jul 2024 | SEK 69.8b | SEK 6.4b | -SEK 868,337,744.92 | 83x | -80.4x | 11x |
| Fri, 07 Jun 2024 | SEK 60.8b | SEK 6.5b | -SEK 871,118,223.79 | 75.5x | -69.8x | 9.4x |
| Sun, 05 May 2024 | SEK 49.6b | SEK 6.3b | -SEK 935,306,041.24 | 66.4x | -53x | 7.9x |
| Tue, 02 Apr 2024 | SEK 51.2b | SEK 6.2b | -SEK 1,038,131,674.52 | 77.6x | -49.4x | 8.2x |
| Thu, 29 Feb 2024 | SEK 46.9b | SEK 6.2b | -SEK 1,041,287,814.56 | 80.1x | -45x | 7.5x |
| Sat, 27 Jan 2024 | SEK 69.0b | SEK 9.5b | -SEK 1,182,168,895.00 | 65.4x | -58.4x | 7.3x |
| Mon, 25 Dec 2023 | SEK 68.0b | SEK 9.4b | -SEK 1,184,189,142.00 | 63x | -57.4x | 7.2x |
| Wed, 22 Nov 2023 | SEK 59.9b | SEK 9.5b | -SEK 1,172,189,523.00 | 53.1x | -51.1x | 6.3x |
| Fri, 20 Oct 2023 | SEK 50.5b | SEK 9.2b | -SEK 1,142,990,886.00 | 105x | -44.2x | 5.5x |
| Sun, 17 Sep 2023 | SEK 50.6b | SEK 9.2b | -SEK 1,177,933,411.00 | 137.6x | -43x | 5.5x |
| Tue, 15 Aug 2023 | SEK 52.9b | SEK 8.9b | -SEK 1,410,542,799.00 | 84.4x | -37.5x | 5.9x |
| Thu, 13 Jul 2023 | SEK 48.3b | SEK 8.4b | -SEK 1,693,236,247.00 | 79.8x | -28.5x | 5.8x |
| Sat, 10 Jun 2023 | SEK 47.1b | SEK 8.4b | -SEK 1,706,792,045.00 | 73.7x | -27.6x | 5.6x |
| Mon, 08 May 2023 | SEK 49.0b | SEK 8.1b | -SEK 1,811,993,872.00 | 70.3x | -27.1x | 6x |
| Wed, 05 Apr 2023 | SEK 45.6b | SEK 8.0b | -SEK 1,793,643,110.00 | 91.9x | -25.4x | 5.7x |
| Fri, 03 Mar 2023 | SEK 44.7b | SEK 8.0b | -SEK 1,783,627,923.00 | 229.9x | -25.1x | 5.6x |
| Sun, 29 Jan 2023 | SEK 47.9b | SEK 7.3b | -SEK 1,965,905,838.00 | 286.1x | -24.4x | 6.6x |
| Tue, 27 Dec 2022 | SEK 48.4b | SEK 7.3b | -SEK 1,910,766,059.00 | 276.3x | -25.3x | 6.6x |
| Thu, 24 Nov 2022 | SEK 49.4b | SEK 7.2b | -SEK 1,955,316,814.00 | 48x | -25.3x | 6.9x |
| Sat, 22 Oct 2022 | SEK 48.4b | SEK 7.0b | -SEK 1,754,826,134.00 | 47.6x | -27.6x | 6.9x |
| Mon, 19 Sep 2022 | SEK 50.2b | SEK 7.0b | -SEK 1,739,378,174.00 | 47.8x | -28.9x | 7.2x |
| Wed, 17 Aug 2022 | SEK 57.5b | SEK 6.9b | -SEK 1,538,018,762.00 | 40.4x | -37.4x | 8.4x |
| Fri, 15 Jul 2022 | SEK 49.0b | SEK 5.9b | -SEK 1,509,116,648.00 | 43.4x | -32.5x | 8.3x |
| Sun, 12 Jun 2022 | SEK 52.1b | SEK 5.9b | -SEK 1,505,666,101.00 | 46.2x | -34.6x | 8.8x |
| Tue, 10 May 2022 | SEK 46.7b | SEK 5.5b | -SEK 1,271,512,557.00 | 35.6x | -36.8x | 8.5x |
| Thu, 07 Apr 2022 | SEK 56.2b | SEK 5.5b | -SEK 1,335,083,342.00 | 40x | -42.1x | 10.2x |
| Sat, 05 Mar 2022 | SEK 48.1b | SEK 5.4b | -SEK 1,373,958,123.00 | 31.8x | -35x | 8.9x |
| Mon, 31 Jan 2022 | SEK 48.0b | SEK 5.3b | -SEK 1,103,445,827.00 | 72.5x | -43.5x | 9x |
Price to Earnings Ratio
-43.5x
Current Industry PE
- Investors are optimistic on the Swedish Pharmaceuticals industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 8.1x is lower than the industry's current PS ratio of 11.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 5.8% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare industry?
| SE Market | 3.26% | |
| Healthcare | 0.18% | |
| Pharma | 1.80% | |
| Pharma | 1.80% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CAMX Camurus | SEK 598.00 | 2.1% +SEK 735.1m | 17.5% | PE132.1x | |
| SECARE Swedencare | SEK 48.00 | 2.0% +SEK 152.5m | -25.0% | PE122.8x | |
| MOB Moberg Pharma | SEK 9.77 | 9.5% +SEK 39.7m | -38.6% | PS51.9x | |
| CESSA Cessatech | DKK 11.90 | 13.3% +DKK 24.4m | 83.1% | PS61.8x | |
| CLBIO Corline Biomedical | SEK 10.45 | 17.7% +SEK 33.7m | -30.1% | PS9.5x |